Document Detail

Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects.
MedLine Citation:
PMID:  21261507     Owner:  NLM     Status:  Publisher    
Abstract Purpose. Survivors after malignant lymphoma are at high risk of late effects. In order to take full responsibility for their own health they need knowledge about their diagnosis, treatment and risk of late effects. We assessed such knowledge in adult survivors of childhood malignant lymphoma. Material and methods. In 2007-2009 128 five-year survivors after childhood malignant lymphoma participated in a national cross-sectional questionnaire-based survey combined with clinical examination. [Males: 69, females: 59, treatment period 1970-2000, median age (range) at diagnosis: 14 years (0-18), at survey: 32 years (19-55), Hodgkin lymphoma (HL): 84, Non-Hodgkin lymphoma (NHL): 44]. Prior to the clinical examination a semi-structured interview on the survivors' knowledge was conducted by a study nurse. The individual survivors' responses were compared with his/her medical record. Results. One hundred and twenty one reported their diagnosis correctly, seven reported that they had cancer, but could not specify malignant lymphoma. Thirty-three could not differentiate between HL and NHL. One hundred and twenty three reported their treatment modalities correctly (radiotherapy vs. chemotherapy vs. combined). Eighty-five (66%) were not aware of any risks for late effects. The remaining 43 listed at least one of the following late effects; infertility, heart-problems, impaired dental status, hypothyroidism, breast cancer, reduced muscle growth, fatigue and reduced memory or concentration. Thirty-seven survivors who provided additional comments reported that they had received some information about risk of late effects from their therapists. Age at diagnosis or educational level were not associated with knowledge about possible late effects while treatment period was. Conclusions. Norwegian long-term survivors of childhood malignant lymphomas are showing improved level of knowledge of their diagnosis and treatment modalities during the last decade. Still, independent of age at diagnosis and level of education, they are insufficiently aware of their risk of late effects.
Siri L Hess; Inga M Jóhannsdóttir; Hanne Hamre; Cecilie E Kiserud; Jon H Loge; Sophie D Fosså
Related Documents :
9850767 - Lipoblastic meningioma. case report.
19703267 - Rosai-dorfman disease isolated to the central nervous system: a report of six cases.
21188067 - Hot tongue on fdg pet scan in a patient of hodgkin's lymphoma undergoing antipsychotic ...
3775637 - Cystic lesions associated with meningiomas.
24262607 - Value of diagnosis imaging in the evaluation of the severity of histological lesions in...
11770017 - Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-24
Journal Detail:
Title:  Acta oncologica (Stockholm, Sweden)     Volume:  -     ISSN:  1651-226X     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709065     Medline TA:  Acta Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
National Resource Center for Late Effects, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduction in waiting time for diagnosis and treatment of head and neck cancer - a fast track study.
Next Document:  Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patient...